← FDA Drug Approvals (Drugs@FDA)

WEGOVY

NDA · New Drug Application · Sponsor: NOVO · Approved 2021-06-04

Drug application

FDA Application #

NDA215256

Application type

New Drug Application

Brand name

WEGOVY

Generic name

SEMAGLUTIDE

Active ingredients

SEMAGLUTIDE

Dosage form

SOLUTION

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

NOVO

Manufacturer

Novo Nordisk

First approval

2021-06-04

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown